Maximum Strength Acid Reducer
NDC 11673-697, Famotidine, tablet, from TARGET CORPORATION.
- Product NDC
- 11673-697
- Status
- Listed
- Labeler
- TARGET CORPORATION
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA217543
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11673-697 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE20 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11673-697-01 | 11673069701 | 2 BOTTLE in 1 CARTON (11673-697-01) / 50 TABLET in 1 BOTTLE |
| 11673-697-05 | 11673069705 | 1 BOTTLE in 1 CARTON (11673-697-05) / 50 TABLET in 1 BOTTLE |
| 11673-697-20 | 11673069720 | 1 BOTTLE in 1 CARTON (11673-697-20) / 200 TABLET in 1 BOTTLE |
| 11673-697-52 | 11673069752 | 5 BLISTER PACK in 1 CARTON (11673-697-52) / 5 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11673-697 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11673-697 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11673-697. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.